SCHEMBL25324202

SCHEMBL25324202

O=C(N1CC(NCc2cc(Cl)cc(C(F)(F)F)c2)C1)N1CC2(CC(c3nnc(C4CC4)[nH]3)C2)C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 2/20 0.38
▸ TEAD1 P28347 3/20 0.36
▸ ENPP2 Q13822 5/20 0.35
▸ ATXN2 Q99700 4/20 0.35
▸ CCR2 P41597 4/20 0.34
▸ HDAC3 O15379 1/20 0.32
▸ HDAC4 P56524 1/20 0.32
▸ HDAC1 Q13547 1/20 0.32
▸ HDAC7 Q8WUI4 1/20 0.32
▸ HDAC2 Q92769 1/20 0.32
▸ HDAC10 Q969S8 1/20 0.32
▸ HDAC11 Q96DB2 1/20 0.32
▸ HDAC8 Q9BY41 1/20 0.32
▸ HDAC6 Q9UBN7 1/20 0.32
▸ HDAC9 Q9UKV0 1/20 0.32
▸ HDAC5 Q9UQL6 1/20 0.32
▸ FFAR4 Q5NUL3 1/20 0.32
▸ BTK Q06187 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30553134 1.00 FAAH (0.38) FAAHTEAD1ENPP2ATXN2CCR2
SCHEMBL25325112 0.87 TEAD1 (0.44) TEAD1CCR2HDAC3HDAC4HDAC1
SCHEMBL25324075 0.84 P2RX7 (0.37) TEAD1MGLL
SCHEMBL25325226 0.84 FAAH (0.38) FAAHTEAD1CCR2FFAR4MGLL
SCHEMBL25322265 0.83 POLB (0.39) TEAD1ENPP2ATXN2POLBMGLL
SCHEMBL30553285 0.82 FAAH (0.36) FAAHMGLL
SCHEMBL25325576 0.82 FAAH (0.36) FAAHMGLL
SCHEMBL25325835 0.81 MGLL (0.37) TEAD1ENPP2ATXN2MGLL
SCHEMBL25323130 0.81 PDE2A (0.37) TEAD1BTKMGLLKCNH2
SCHEMBL25322558 0.79 BCHE (0.41) ENPP2ATXN2HDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250099448-A1 HETEROCYCLIC COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2025-03-27 — — US claimed
WO-2023144160-A1 NEW HETEROCYCLIC COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2023-08-03 — — WO claimed
US-20250099448-A1 HETEROCYCLIC COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2025-03-27 — — US disclosed
WO-2023144160-A1 NEW HETEROCYCLIC COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2023-08-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250099448-A1 HETEROCYCLIC COMPOUNDS OPRM1, CYP1A1, CYP3A4 FAAH 451/4885TEAD1 3390/4885ENPP2 3934/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback